PLP2, a potent deubiquitinase from murine hepatitis virus, strongly inhibits cellular type I interferon production

Dahai Zheng1, Gang Chen, Beichu Guo

  • 1Center for Infection and Immunity, Institute of Biophysics, Chinese Academy of Sciences, 15 Da Tun Road, Chaoyang District, Beijing 100101, China.

Cell Research
|October 30, 2008
PubMed

Insights

Coronaviruses evade host immunity by suppressing type I interferon production. This study identifies a viral protease, Papain-like protease domain 2 (PLP2), that inhibits interferon signaling by deubiquitinating IRF3.

Area of Science:

  • Virology
  • Immunology
  • Molecular Biology

Background:

  • Coronaviruses, including SARS-CoV, cause limited type I interferon (IFN) production, linked to severe disease.
  • The precise molecular mechanisms behind this suppressed IFN response in coronavirus infections are not fully understood.

Purpose of the Study:

  • To elucidate the molecular mechanisms by which coronaviruses inhibit host type I interferon production.
  • To identify specific viral factors involved in evading innate antiviral responses.

Main Methods:

  • Investigated the interaction between the coronavirus nonstructural protein 3 (nsp3) Papain-like protease domain 2 (PLP2) and IRF3.
  • Assessed the effect of PLP2 on IRF3 ubiquitination and nuclear translocation using co-expression systems.
  • Measured IFN-beta reporter gene activity upon co-expression of PLP2 and components of the IFN signaling pathway (CARDIF, TBK1, IRF3).
  • Evaluated the impact of wild-type and catalytically inactive PLP2 on viral replication (VSV) and IFN induction in infected cells.

Main Results:

  • Papain-like protease domain 2 (PLP2) of MHV-A59 binds to IRF3, promoting its deubiquitination.
  • PLP2 inhibits the nuclear translocation of IRF3, a key transcription factor for IFN production.
  • Co-expression of PLP2 significantly suppresses IFN-beta reporter activity mediated by CARDIF, TBK1, and IRF3.
  • Wild-type PLP2, but not a mutant lacking deubiquitinase (DUB) activity, reduces IFN induction and enhances viral growth in VSV-infected cells.

Conclusions:

  • Uncovered a viral deubiquitinase (DUB) activity within the coronavirus PLP2 domain.
  • Coronaviruses likely utilize this PLP2 DUB to interfere with IRF3 activation and evade host innate antiviral immunity.
  • This finding provides a molecular explanation for the impaired IFN response observed in coronavirus infections.

Related Concept Videos

Inhibitors of Viral Protein Synthesis01:30

Inhibitors of Viral Protein Synthesis

Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...
Inhibitors Of Virion Release01:25

Inhibitors Of Virion Release

Viral replication and dissemination rely on efficient mechanisms for host cell entry, genome replication, assembly, and release. Influenza viruses, such as types A and B, are negative-sense single-stranded RNA viruses with a segmented genome, that depend on two critical surface glycoproteins to carry out these processes: hemagglutinin (HA) and neuraminidase (NA). HA initiates infection by binding to sialic acid residues on the surface of host epithelial cells, facilitating receptor-mediated...
Inhibitors of Virion Maturation and Assembly01:19

Inhibitors of Virion Maturation and Assembly

As part of their replication cycle, certain viruses synthesize long precursor proteins called polyproteins within infected host cells. In human immunodeficiency virus (HIV), two major polyproteins are produced: Gag and Gag-Pol. The Gag polyprotein supplies the structural components of the virus, while Gag-Pol includes essential viral enzymes such as reverse transcriptase, integrase, and protease. After synthesis, these polyproteins move to the host cell membrane, where they assemble into an...